Inc. profiles the women's telehealth company, whose study of over 8,000 women reported gains in weight, blood sugar and cholesterol, per SheMed.
Recap by typeshit. Full story at Inc.com.
The $49 virtual weight management visits now cover insurance checks and Medicare GLP-1 Bridge support, with pharmacists contacting everyone who starts a fill.
A press release announces Woodward's new book, which she says debunks common peptide myths aimed at women. No other details were given.
A local feature on clinics in Sarasota using peptides for recovery, hormones and wellness. The claims come from the practitioners and are not backed by cited evidence.
Endpoints News
The Copenhagen drugmaker has a slate of weight loss candidates but says its future depends on building a much wider pipeline.
Vomiting fell to 43% of patients on tradipitant versus 58.5% on placebo. Vanda plans to seek an expanded approval for GLP-1-induced vomiting.
BusinessWorld Online covers new trial results for Lilly's retatrutide and what the drug could mean for patients going forward.
Loading…